FGP
SEM

Freestone Grove Partners’s Select Medical SEM Stock Holding History

Freestone Grove Partners’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-205,589
Closed -$3.43M – 833
2025
Q1 		$3.43M Buy
+205,589
New +$3.78M 0.04% 295

Other funds holding SEM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Freestone Grove Partners's SEM Position: Q2 2025 in Review

Freestone Grove Partners sold out of Select Medical (SEM) in Q2 2025, closing a stake of 205,589 shares — an estimated $3.43M sold.

Freestone Grove Partners first reported a position in SEM in Q1 2025 and held it in 1 quarter. The position peaked at $3.43M in Q1 2025. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

  • Freestone Grove Partners reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 205,589 Select Medical shares in Q2 2025, an estimated $3.43M.
  • Freestone Grove Partners first reported a position in Select Medical in Q1 2025 and held it in 1 quarter.
  • Freestone Grove Partners's Select Medical position peaked at $3.43M in Q1 2025.
  • 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Freestone Grove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.